Analyst firms · BofA Securities · SGRY

BofA Securities SGRY price target and rating history

Surgery Partners Inc. (SGRY) · Health Care

BofA Securities rates Surgery Partners Inc. (SGRY) Buy with a $28 price target, as of its latest action on Jul 28, 2025. It has published 4 rating actions on SGRY since June 2022, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$28
Median target, all firms
Too few
Actions on SGRY
4

BofA Securities price target on SGRY

$45$37$282023202420252026
BofA Securities price target on SGRY, each point a stated target, June 2022 to July 2025.

Every BofA Securities rating on SGRY

Questions about BofA Securities and SGRY

What is BofA Securities's price target for SGRY?
BofA Securities's latest stated price target for Surgery Partners Inc. (SGRY) is $28, from its action on Jul 28, 2025.
What is BofA Securities's rating on SGRY?
BofA Securities rates SGRY Buy, a bullish rating, as of Jul 28, 2025.
When did BofA Securities last change its view on SGRY?
On Jul 28, 2025, BofA Securities resumes coverage at Buy, price target $28.

More SGRY rating histories

All BofA Securities ratingsSGRY news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.